News
Johns Hopkins finds positive result in COVID-19 ARDS treated patients with Cellenkos' Cord Blood cells
Physician-investigators at the Johns Hopkins University Hospital found promising data of treatment of COVID-19 induced ARDS with allogeneic, cord blood derived T-regulatory (Treg) cell therapy
AstraZeneca’s Dapagliflozin gets approval for treatment of Heart Failure patients with reduced ejection fraction
This is the first in class SGLT-2 inhibitor drug approved for the treatment of HFrEF and is the first drug proven to significantly reduce the risk of Cardiovascular death
Dr Reddy’s Labs, ABLE member, to make Favipiravir with Fujifilm Toyoma tie-up for India, global markets treat COVID-19
A Tripartite Licensing Agreement was concluded between Fujifilm Toyama, Dr. Reddy's Laboratories and GRA, concerning the development, manufacture and sales of Favipiravir ( Avigan) tablets used to treat COVID-19 patients
Pfizer, BioNTech announce early positive data from an ongoing phase 1/2 study of SARS-COV-2 vaccine
Pfizer and BioNTech SE have announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program.
BioEconomy Conclave 2026
